These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7911303)

  • 21. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.
    Schoemaker H; Claustre Y; Fage D; Rouquier L; Chergui K; Curet O; Oblin A; Gonon F; Carter C; Benavides J; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):83-97. PubMed ID: 8996185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of dopamine agonists upon stimulated limbic and striatal dopamine release: in vivo voltammetric data.
    Stamford JA; Kruk ZL; Millar J
    Br J Pharmacol; 1991 Jan; 102(1):45-50. PubMed ID: 1675147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Savoxepine fails to selectively influence glucose metabolism in the rat limbic system.
    Cascella NG; Tarazi FI; Shirakawa O; Tamminga CA
    Psychopharmacology (Berl); 1994 Mar; 114(2):275-80. PubMed ID: 7838920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Responses of limbic and extrapyramidal substance P systems to nicotine treatment.
    Alburges ME; Frankel PS; Hoonakker AJ; Hanson GR
    Psychopharmacology (Berl); 2009 Jan; 201(4):517-27. PubMed ID: 18773198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine autoreceptor agonists as potential antipsychotics. 3.6-Propyl-4,5,5a,6,7,8-hexahydrothiazolo[4,5-f]quinolin-2-amine.
    Caprathe BW; Jaen JC; Wise LD; Heffner TG; Pugsley TA; Meltzer LT; Parvez M
    J Med Chem; 1991 Sep; 34(9):2736-46. PubMed ID: 1680195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased site-specific phosphorylation of tyrosine hydroxylase accompanies stimulation of enzymatic activity induced by cessation of dopamine neuronal activity.
    Lew JY; Garcia-Espana A; Lee KY; Carr KD; Goldstein M; Haycock JW; Meller E
    Mol Pharmacol; 1999 Feb; 55(2):202-9. PubMed ID: 9927609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological characterization of PD 118717, a putative piperazinyl benzopyranone dopamine autoreceptor agonist.
    Pugsley TA; Christofferson CL; Corbin A; DeWald HA; Demattos S; Meltzer LT; Myers SL; Shih YH; Whetzel SZ; Wiley JN
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1147-58. PubMed ID: 1361570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of stimulants of abuse on extrapyramidal and limbic neuropeptide Y systems.
    Westwood SC; Hanson GR
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1160-6. PubMed ID: 10027854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced cortical dopamine output and antipsychotic-like effect of raclopride with adjunctive low-dose L-dopa.
    Eltayb A; Wadenberg ML; Svensson TH
    Biol Psychiatry; 2005 Aug; 58(4):337-43. PubMed ID: 16102547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing sertindole to other new generation antipsychotics on preferential dopamine output in limbic versus striatal projection regions: mechanism of action.
    Hertel P
    Synapse; 2006 Dec; 60(7):543-52. PubMed ID: 16952163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation by D2 dopamine receptors of in vivo dopamine synthesis in striata of rats and mice with experimental parkinsonism.
    Richard MG; Bennett JP
    Exp Neurol; 1994 Sep; 129(1):57-63. PubMed ID: 7925842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of cocaine on extrapyramidal and limbic dynorphin systems.
    Smiley PL; Johnson M; Bush L; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1990 Jun; 253(3):938-43. PubMed ID: 1972755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre- and postsynaptic actions of a partial D2 receptor agonist in reserpinized young rats: longevity of agonistic effects.
    Farley CM; Baella SA; Wacan JJ; Crawford CA; McDougall SA
    Brain Res; 2006 Dec; 1124(1):37-44. PubMed ID: 17070785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different effects of chronic administration of haloperidol and pimozide on dopamine metabolism in the rat brain.
    Karolewicz B; Antkiewicz-Michaluk L; Michaluk J; Vetulani J
    Eur J Pharmacol; 1996 Oct; 313(3):181-6. PubMed ID: 8911913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FCE 23884, substrate-dependent interaction with the dopaminergic system. II. Preclinical biochemical studies.
    Carfagna N; Caccia C; Mantegani S; Cavanus S; Fornaretto MG; Buonamici M; Rossi AC; Roncucci R; Fariello RG
    J Pharmacol Exp Ther; 1991 Oct; 259(1):356-64. PubMed ID: 1681088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine agonist action in mesolimbic, cortical and extrapyramidal areas to modify spontaneous climbing behaviour of the mouse.
    Costall B; Eniojukan JF; Naylor RJ
    Psychopharmacology (Berl); 1985; 86(4):452-7. PubMed ID: 3929317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1976 Nov; 40(1):9-19. PubMed ID: 791660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the quantitative structure-activity relationships of meta-substituted (S)-phenylpiperidines, a class of preferential dopamine D2 autoreceptor ligands: modeling of dopamine synthesis and release in vivo by means of partial least squares regression.
    Hansson LO; Waters N; Holm S; Sonesson C
    J Med Chem; 1995 Aug; 38(16):3121-31. PubMed ID: 7636874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential agonist profile of the enantiomers of 3-PPP at striatal dopamine autoreceptors: dependence on extracellular dopamine.
    Clark D; Salah RS; Galloway MP
    Synapse; 1991 Jul; 8(3):169-76. PubMed ID: 1948667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential responses by neurotensin systems in extrapyramidal and limbic structures to ibogaine and cocaine.
    Alburges ME; Hanson GR
    Brain Res; 1999 Feb; 818(1):96-104. PubMed ID: 9914442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.